Boehringer Ingelheim has appointed Harsha Deshmukh to its Executive Leadership Team. Starting February 1, 2026, he will lead IT and Global Business Services, strengthening the company’s digital transformation.
COPD affects millions in Germany – many are unaware of their condition. World COPD Day highlights the importance of early diagnosis and modern care pathways.
With “Life with Glioma,” Servier Germany introduces a new, science-based information platform for individuals affected by low-grade, IDH-mutated gliomas. The website provides guidance from diagnosis through follow-up care.
The new podcast “Plan B from Now On” accompanies families with seriously ill or disabled children and sheds light on their daily challenges, their strength, and the need for greater societal support. Hosted by Katrin Eigendorf and Dr. Eckart von Hirschhausen.
dm is preparing to launch its own mail-order pharmacy, expanding its role as a healthcare provider. At the same time, the company is accelerating its investments in digitalization, omnichannel services, and store modernization.
AAA-Pharma and XO Life combine their expertise to support patients with chronic conditions through high-quality generics and digital therapy guidance. The collaboration strengthens care quality and enhances patient orientation.
The new GSK initiative “BACK TO YOU” offers practical support, inspiration and emotional guidance for people living with Multiple Myeloma and their families—especially during relapse phases. A card set, a video podcast and active social media channels accompany patients on their path back to greater strength.
The German Medical Association joins the UN campaign “Orange the World” and calls for greater protection, awareness, and low-threshold support offers for women affected by violence. Physicians play a key role in victim protection.
gesund.de is elevating the local presence of community pharmacies and demonstrating how digital reach and personal in-store service can reinforce one another. The new Joint Marketing Campaign actively involves around 30 pharmacies in its development and execution.
FUNKE, together with leading partners from research, politics, patient organizations, and industry, has launched the initiative “STUDIEN WIRKEN.” The goal is to increase visibility for clinical studies, build trust, and strengthen Germany’s research landscape.
